SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
MabVax Therapeutics, Inc. Receives SBIR Program Award From the National Cancer Institute to Manufacture Clinical Supplies for Phase 2 Neuroblastoma Trial
Your Message